Clincosm LogoSign in Get a demo

Hodgkin Lymphoma

Showing NaN - NaN of 8
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Reserve in Younger Newly Diagnosed Lymphomas

Active, not recruiting
  • Anaplastic Large Cell Lymphoma
  • +4 more
  • Laboratory Biomarker Analysis
  • Questionnaire Administration
  • Birmingham, Alabama
  • +106 more
Jan 11, 2023

Participated in Children's Oncology Group Studies

Recruiting
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Assessment of Therapy Complications
  • Questionnaire Administration
  • Birmingham, Alabama
  • +163 more
Sep 6, 2022

Hematologic Malignancy, AML, ALL Trial in Australia, United States (Tagraxofusp, Fludarabine, Cytarabine)

Not yet recruiting
  • Hematologic Malignancy
  • +10 more
  • Los Angeles, California
  • +28 more
Jul 26, 2022

Hodgkin Lymphoma Trial in United States (Ruxolitinib, Nivolumab)

Recruiting
  • Hodgkin Lymphoma
  • Chicago, Illinois
  • +4 more
Feb 16, 2022

Non-hodgkin Lymphoma, Hodgkin Lymphoma, Lymphoma Trial in Chicago (Radiation - Dose Level 0, Radiation - Dose Level 1, Radiation

Recruiting
  • Non-hodgkin Lymphoma
  • +2 more
  • Radiation - Dose Level 0
  • +4 more
  • Chicago, Illinois
    University of Chicago
Dec 3, 2021

Hodgkin Lymphoma Trial in United States (PLX3397)

Completed
Has Results
  • Hodgkin Lymphoma
  • Los Angeles, California
  • +5 more
Jun 18, 2020

Hodgkin Lymphoma Trial in United States (Everolimus (RAD001))

Completed
Has Results
  • Hodgkin Lymphoma
  • Everolimus (RAD001)
  • Los Angeles, California
  • +15 more
Apr 18, 2016

Hodgkin Lymphoma, Anaplastic Large Cell Lymphoma Trial in United States (XmAb2513)

Completed
  • Hodgkin Lymphoma
  • Anaplastic Large Cell Lymphoma
  • XmAb2513
  • Chicago, Illinois
  • +3 more
Apr 18, 2014